Home U.S. FDA panel: data support safety, efficacy of Merck allergy drug
 

Keywords :   


U.S. FDA panel: data support safety, efficacy of Merck allergy drug

2014-01-28 23:10:31| Biotech - Topix.net

Merck & Co's experimental allergy drug, Ragwitek, appears safe and effective for use in patients between the ages of 18 and 65, a panel of advisors to the U.S. Food and Drug Administration concluded on Tuesday.

Tags: support data safety panel

Category:Biotechnology and Pharmaceuticals

Latest from this category

All news

»
25.11dura ace 32H
25.11 (S)
25.111592 33mm 33mm
25.11 DVD 7
25.11DR4270
25.11A +A act2
25.115 SEED FREEDOM
25.11
More »